![Berndt A. E. Modig](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Berndt A. E. Modig
Fondatore presso PHARVARIS N.V.
Patrimonio netto: 29 M $ in data 31/05/2024
Profilo
Mr. Berndt A.
E.
Modig is a Chief Executive Officer & Director at Pharvaris GmbH, a Chief Executive Officer & Executive Director at Pharvaris NV and a Managing Director at Schoodic Management BV.
He is on the Board of Directors at Centogene AG, Pharvaris GmbH, Pharvaris NV, OncoBiotek SA and Roivant Sciences, Inc. Mr. Modig was previously employed as an Independent Member-Supervisory Board by Centogene NV, a Vice Chairman-Supervisory Board by Kiadis Pharma NV, an Independent Non-Executive Director by Auris Medical Holding AG /Old/, an Independent Director by Sio Gene Therapies, Inc., a Member-Supervisory Board by Affimed NV, a Member-Supervisory Board by Affimed GmbH, a Chief Financial Officer by Prosensa Holding NV, a Chief Financial Officer by Jerini AG, a Chief Financial Officer by Surplex.com AG, a Finance Director-Europe by Hayward Industrial Products, Inc., a Partner by Agra Industria, and a Senior Manager-Financial Services by Pricewaterhouse LLP.
He also served on the board at Auris Medical Holding Ltd., Mobile Loyalty Plc and Auris Medical AG.
He received his undergraduate degree from the University of Lund and an MBA from INSEAD.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
PHARVARIS N.V.
2.80% | 01/04/2024 | 1 504 791 ( 2.80% ) | 29 M $ | 31/05/2024 |
Posizioni attive di Berndt A. E. Modig
Società | Posizione | Inizio |
---|---|---|
PHARVARIS N.V. | Fondatore | 30/09/2015 |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Direttore/Membro del Consiglio | - |
Centogene AG
![]() Centogene AG Medical/Nursing ServicesHealth Services Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany. | Direttore/Membro del Consiglio | 04/05/2018 |
OncoBiotek SA
![]() OncoBiotek SA BiotechnologyHealth Technology OncoBiotek SA engages in the provision of biotechnology research and development. The company was founded on January 1, 2009 and is headquartered in Châteauneuf-Villevieille, France. | Direttore/Membro del Consiglio | - |
Schoodic Management BV | Amministratore Delegato | - |
Pharvaris GmbH
![]() Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Fondatore | 01/10/2015 |
Precedenti posizioni note di Berndt A. E. Modig
Società | Posizione | Fine |
---|---|---|
CENTOGENE N.V. | Direttore/Membro del Consiglio | 15/08/2023 |
SIO GENE THERAPIES INC. | Direttore/Membro del Consiglio | 05/04/2023 |
KIADIS PHARMA N.V. | Direttore/Membro del Consiglio | 01/04/2021 |
░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░ ░░░░░░░ ░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Berndt A. E. Modig
INSEAD | Masters Business Admin |
University of Lund | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
AFFIMED N.V. | Health Technology |
PHARVARIS N.V. | Health Technology |
ALTAMIRA THERAPEUTICS LTD. | Health Technology |
CENTOGENE N.V. | Commercial Services |
Aziende private | 17 |
---|---|
Shire Orphan Therapies GmbH
![]() Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Health Technology |
Surplex AG
![]() Surplex AG Internet Software/ServicesTechnology Services Surplex AG operates an online business-to-business exchange for surplus assets and excess inventory. The private company is based in Dusseldorf, Germany. | Technology Services |
Pricewaterhouse LLP | Commercial Services |
Prosensa Holding NV
![]() Prosensa Holding NV BiotechnologyHealth Technology Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands. | Health Technology |
Auris Medical Holding AG /Old/
![]() Auris Medical Holding AG /Old/ Medical SpecialtiesHealth Technology Auris Medical Holding AG engages in the research, development, and commercialization of pharmaceutical products for inner ear disorders. Its products portfolio targets to treat tinnitus, Menière's disease, and hearing loss. The company was founded by Thomas Meyer on April 1, 1998 and is headquartered in Zug, Switzerland. | Health Technology |
Sio Gene Therapies, Inc.
![]() Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Auris Medical AG
![]() Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Health Technology |
Schoodic Management BV | |
Hayward Industrial Products, Inc.
![]() Hayward Industrial Products, Inc. Industrial MachineryProducer Manufacturing Hayward Industrial Products, Inc. supplies swimming pool equipment, industrial valves, strainers, and fittings. The company is headquartered in Elizabeth, NJ. | Producer Manufacturing |
Agra Industria | |
Mobile Loyalty Plc
![]() Mobile Loyalty Plc Advertising/Marketing ServicesCommercial Services Mobile Loyalty Plc operates as a holding company with interests in mobile advertising services. The company was founded by Sterner de la Mau in 2007 and is headquartered in Malmo, Sweden. | Commercial Services |
Kiadis Pharma NV
![]() Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Kiadis Pharma NV engages in pharmaceutical development of cell-based immunotherapy products in the field of diseases of the blood building system. Its lead product is the ATIR101. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
OncoBiotek SA
![]() OncoBiotek SA BiotechnologyHealth Technology OncoBiotek SA engages in the provision of biotechnology research and development. The company was founded on January 1, 2009 and is headquartered in Châteauneuf-Villevieille, France. | Health Technology |
Centogene AG
![]() Centogene AG Medical/Nursing ServicesHealth Services Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany. | Health Services |
Affimed GmbH
![]() Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Commercial Services |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
Pharvaris GmbH
![]() Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Berndt A. E. Modig